Compare · head to head
Dong-A ST vs Handok
Dong-A ST ranks higher overall — 360 rank 39 vs 15.
Dong-A ST leads on Value (57 vs 51) and Quality (57 vs 52). The two are close on Safety and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Small |
| ISIN | KR7170900005 | KR7002390003 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 39 | 15 |
| Value | 57 | 51 |
| Quality | 57 | 52 |
| Growth | 60 | NR |
| Safety | 19 | 16 |
| Sentiment | 44 | 40 |
| Quality details | ||
| Profitability | 57 | 52 |
| Cash Truth | 58 | 51 |
Dong-A ST vs CSPC PharmaceuticalDong-A ST vs Bukwang PharmaceuticalDong-A ST vs Kwangdong PharmaceuticalDong-A ST vs Il Dong PharmaceuticalAdd a third stock →
Full analyses: Dong-A ST · Handok
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100